#CGAIGC24

Financial Disclosures

2024 Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Annual Meeting

November 14-16, 2024

Financial Disclosures

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified financial relationships are thoroughly mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity. These relationships have been mitigated:

 

Mohammad Abbass has no relevant financial relationships to report.  

Sanjeevani Arora has no relevant financial relationships to report.

Melyssa Aronson has no relevant financial relationships to report.

Lisen Axell reports serving as a consultant/advisory board member for Sago global market research. 

Josie Baker has no relevant financial relationships to report.

Kathryn Baker has no relevant financial relationships to report.

Francesc Balaguer reports receiving grants from the Instituto de Salud Carlos III (Ministry of Health), Spain. Also reports serving as a consultant for Olympus, Persei Vivarium, Nouscom; Editorial fees from Elsevier.

Veroushka Ballester has no relevant financial relationships to report.  

Ajay Bansal reports serving as a consultant/advisory board member with Stella Diagnostics.

Amit Bhatt reports serving on a speakers bureau/receiving honoraria from Medtronic, Boston Scientific, Steris, Olympus, and Noah.  Also reports being a patent holder with Medtronic.

Cassidy Rose Bowden has no relevant financial relationships to report. 

Randy Brand reports receiving grant/research support from Immunovia.  He also serves on the advisory board for Immunovia. 

Brian Christopher Brajcich has no relevant financial relationships to report. 

Carol Burke reports receiving grant/research support from Emtora Biosciences.  Serves on the speakers bureau for Ambry Genetics.  Also reports serving as a consultant/advisory board member for Sebela Pharmaceuticals; Emtora Biosciences; Guardant Health, Almirall, and Lumabridge. Reports receiving other financial or material support from Medtronic, Genzyme, Myriad Genetics, Ferring Pharmaceuticals, AbbVie Inc., Salix Pharmaceuticals, and Merck Pharmaceuticals.

Hannah Campbell has no relevant financial relationships to report.

Lee-May Chen has no relevant financial relationships to report.

Jordan Clawson has no relevant financial relationships to report. 

Michael Cruise has no relevant financial relationships to report.

Jeremy Davis has no relevant financial relationships to report. 

Pooja Dharwadkar has no relevant financial relationships to report.

Susan Domchek has no relevant financial relationships to report.

Mev Dominguez Valentin reports serving as a consultant/advisory board member for Nouscom.

Christine Drogan has no relevant financial relationship to report.

Beth Dudley Yurkovich has no relevant financial relationships to report.

Mohamed Elshawy has no relevant financial relationships to report. 

Edward Esplin reports being an employee at Labcorp Genetics, Inc and a former employee of Invitae. He also reports serving as an advisor of Taproot Health, Exir Bio, and ROMTech. He also reports being a stockholder of Labcorp Genetics, Inc., Taproot Health, Exir Bio, and ROMTech. He also reports being a patent holder US Patent 6,743,906 “PPP2R1B is a Tumor Suppressor” · Issued Jun 1, 2004, No royalties paid as a result.

Zach Foda reports being a patent beneficiary of Delfi Diagnostics.

Joel Gabre has no relevant financial relationship to report.

Ophir Gilad has no relevant financial relationships to report. 

Joyce Gong has no relevant financial relationships to report. 

Stephen B Gruber reports receiving research grant support from AbbVie, Eisai, HaloDx and Invitae.

Jose Guillem has no relevant financial relationships to report. 

Michael Hall reports serving as a consultant/advisory board member for Natera. He also reports being a patent holder.

Carla Harmath has no relevant financial relationships to report. 

Jennifer Herrera Mullar reports being an employee of Ambry Genetics.

Rachel Hodan has no relevant financial relationships to report.

Tatiana Johnson has no relevant financial relationships to report. 

Wenora Johnson reports serving as a speaker for GSK and Eisai.

Matthew F Kalady reports serving as a consultant/advisory board member for Activ Surgical.

Fay Kastrinos has no relevant financial relationships to report. 

Bryson Katona reports receiving grant/research support from Guardant, Freenome, Universal Diagnostics, and Recursion. He also serves as an advisory board member for Immunovia.

Katie Lang has no relevant financial relationships to report.

Elana Levinson has no relevant financial relationships to report. 

Samuel Levy has no relevant financial relationship to report. 

Daniel Li has no relevant financial relationships to report.

Xavier Llor has no relevant financial relationships to report.

Jessica Long has no relevant financial relationships to report.

Daniel Luba has no relevant financial relationships to report.

Aimee Lucas reports receiving grant/research support from Immunovia.  She also reports serving as a consultant/advisory board member for ClearNote Health, and UpToDate.

Suzanne MacFarland has no relevant financial relationships to report. 

Lisa Madlensky reports serving as a consultant/advisory board member for VieCure. 

Sukh Makhnoon has no relevant financial relationships to report.

Gautam Mankaney has no relevant financial relationships to report.

Alessandro Mannucci has no relevant financial relationships to report. 

Asaf Maoz has no relevant financial relationships to report.

Kara Maxwell has no relevant financial relationships to report. 

Julie Moskowitz has no relevant financial relationships to report.

Jacqueline Neminski has no relevant financial relationships to report.

Carla Oliveira has no relevant financial relationships to report.

Norma Palma reports being an employee at Immunovia, Inc. She also has stock options in Immunovia, Inc. She is also the inventor on an Immunovia, Inc. patent.

Jacquelyn Powers has no relevant financial relationships to report.

Erica Ramos reports being an employee of Genome Medical, Inc. She also reports being a shareholder in Genome Medical, Inc.

Matteo Repetto has no relevant financial relationships to report.

Douglas Riegert-Johnson has no relevant financial relationships to report.

Sydney Rudowski has no relevant financial relationships to report.

Shenin Sanoba has no relevant financial relationships to report.

Michelle Savage McSweeny has no relevant financial relationships to report.

Kasmintan A Schrader reports receiving grants/research support from AstraZeneca Canada and MERCK.  Also reports serving as a consultant with AstraZeneca Canada and Precision Rx-Dx. Also reports non-mutual funds, stock ownership/stock options with Genetics Adviser.  Also reports being a patent holder with the Provincial Health Services Authority.

Aasma Shaukat reports serving as a consultant for Freenome, Inc. and Iterative Health.

Aparajita Singh has no relevant financial relationships to report.

Joshua Sommovilla has no relevant financial relationships to report.

Michelle Springer has no relevant financial relationships to report.

Peter Stanich has no relevant financial relationships to report.

Carlos Vaccaro has no relevant financial relationships to report.

Jennifer Wagner reports serving as a researcher/consultant to Geisinger Health System.

Steven Waguespack reports serving as a consultant to Bayer and Camurus.

Kirk Wangensteen has no relevant financial relationships to report.

Curtis Weaver has no relevant financial relationships to report.

Jennifer M. Weiss reports receiving research funding from Exact Sciences.

Matthew Yurgelun reports receiving grant funding from Janssen Oncology. He also reports serving as a consultant for Nouscom. He also reports receiving fees for peer review services from UpToDate.

Dana Zakalik has no relevant financial relationships to report. 

Kristin Zelley has no relevant financial relationships to report.

 

The planners at Postgraduate Institute for Medicine (PIM) have no relevant financial relationships to disclose.

The Postgraduate Institute for Medicine (PIM) planners and others have no relevant financial relationships to disclose. The Collaborative Group of the Americas on Inherited Gastrointestinal planners and others have no relevant financial relationships to disclose.